MedMij:V1.0 AddendaInhoudelijkeGegevens: verschil tussen versies
k |
|||
Regel 7: | Regel 7: | ||
<section begin=XXX_Amaya /> | <section begin=XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|J. XXX_Amaya | |style="background-color: white;"|J. XXX_Amaya | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911764 [BSN] | |style="background-color: white;"|999911764 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|6 aug 1964 | |style="background-color: white;"|6 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Amaya /> | |}<section end=XXX_Amaya /> | ||
Regel 31: | Regel 31: | ||
<section begin=MA_XXX_Amaya /> | <section begin=MA_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_1_MA_1 | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 1 dag, om 11:25 | |style="background-color: white;"|T- 1 dag, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|10 maal per dag 1 stuk | |style="background-color: white;"|10 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_1_MA_2 | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:00 | |style="background-color: white;"|T, om 09:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_MA_2 | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 14:32 | |style="background-color: white;"|T, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar afspraak of gebruik: TA |
|style="background-color: white;"|MBH_513_2_TA_1 | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Toelichting |
|style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_3_MA_1 | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 14:32 | |style="background-color: white;"|T, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 28 dagen | |style="background-color: white;"|Vanaf T, gedurende 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar afspraak of gebruik: MGB |
|style="background-color: white;"|MBH_513_3_MGB_1 | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden van voorschrijven |
|style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per week 5 stuks | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_3 | |style="background-color: white;"|MBH_513_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_4_MA_1 | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 5 dagen, om 09:35 | |style="background-color: white;"|T- 5 dagen, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Lichaamslengte |
|style="background-color: white;"|155 | |style="background-color: white;"|155 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Lichaamsgewicht |
|style="background-color: white;"|54 | |style="background-color: white;"|54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aanvullende informatie |
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Toelichting |
|style="background-color: white;"|In overleg met specialist | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MA_XXX_Amaya /> | |}<section end=MA_XXX_Amaya /> | ||
Regel 265: | Regel 265: | ||
<section begin=VV_XXX_Amaya /> | <section begin=VV_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_VV_2 | + | |style="background-color: white;"|MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|2018-08-16T14:32:00 | |style="background-color: white;"|2018-08-16T14:32:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|nog in te vullen, zie word... |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_2_MA_2 | |style="background-color: white;"|MBH_513_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_4_VV_1 | + | |style="background-color: white;"|MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 5 dagen, om 09:35 | |style="background-color: white;"|T- 5 dagen, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afleverlocatie |
|style="background-color: white;"|Huisadres patiënt | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aanvullende wensen |
|style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=VV_XXX_Amaya /> | |}<section end=VV_XXX_Amaya /> | ||
Regel 338: | Regel 338: | ||
<section begin=TA_XXX_Amaya /> | <section begin=TA_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_1_TA_1 | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 12:25 | |style="background-color: white;"|T, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_1_MA_2 | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_TA_1 | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 7 dagen, om 14:52 | |style="background-color: white;"|T- 7 dagen, om 14:52 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 7 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Opname | |style="background-color: white;"|Opname | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_4_TA_1 | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 5 dagen, om 09:45 | |style="background-color: white;"|T- 5 dagen, om 09:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aanvullende informatie |
|style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Toelichting |
|style="background-color: white;"|Wegens niet leverbaar zijn van Broxil | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=TA_XXX_Amaya /> | |}<section end=TA_XXX_Amaya /> | ||
Regel 475: | Regel 475: | ||
<section begin=MVE_XXX_Amaya /> | <section begin=MVE_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_MVE_1 | + | |style="background-color: white;"|MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aanschrijfdatum |
|style="background-color: white;"|T, om 14:32 | |style="background-color: white;"|T, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_513_2_VV_2 | |style="background-color: white;"|MBH_513_2_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_4_MVE_1 | + | |style="background-color: white;"|MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 5 dagen, om 09:45 | |style="background-color: white;"|T- 5 dagen, om 09:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afleverlocatie |
|style="background-color: white;"|Huisadres patiënt | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aanvullende informatie |
|style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Toelichting |
|style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_513_4_VV_1 | |style="background-color: white;"|MBH_513_4_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MVE_XXX_Amaya /> | |}<section end=MVE_XXX_Amaya /> | ||
Regel 542: | Regel 542: | ||
<section begin=MGB_XXX_Amaya /> | <section begin=MGB_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_MGB_1 | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 2 dagen, om 15:39 | |style="background-color: white;"|T- 2 dagen, om 15:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 2 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_MGB_2 | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 20:40 | |style="background-color: white;"|T, om 20:40 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 1 dag, tot nader order | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Informant |
− | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | + | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_2_MGB_3 | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 21:39 | |style="background-color: white;"|T, om 21:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Informant |
− | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 20:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde verstrekking |
|style="background-color: white;"|MBH_5132_2_MVE_1 | |style="background-color: white;"|MBH_5132_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_5132_2 | |style="background-color: white;"|MBH_5132_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_3_MGB_1 | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 3 dagen, om 20:59 | |style="background-color: white;"|T- 3 dagen, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per week 5 stuks | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_513_3_MA_1 | |style="background-color: white;"|MBH_513_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden gebruik |
|style="background-color: white;"|Lymfekanker | |style="background-color: white;"|Lymfekanker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_3 | |style="background-color: white;"|MBH_513_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_513_4_MGB_1 | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 4 dagen, om 22:35 | |style="background-color: white;"|T- 4 dagen, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MGB_XXX_Amaya /> | |}<section end=MGB_XXX_Amaya /> | ||
Regel 826: | Regel 826: | ||
<section begin=XXX_Bourgonje /> | <section begin=XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|Pauline P. XXX_Bourgonje | |style="background-color: white;"|Pauline P. XXX_Bourgonje | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911296 [BSN] | |style="background-color: white;"|999911296 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Bourgonje /> | |}<section end=XXX_Bourgonje /> | ||
Regel 850: | Regel 850: | ||
<section begin=MA_XXX_Bourgonje /> | <section begin=MA_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_123_1_MA_1 | + | |style="background-color: white;"|MBH_123_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 7 dagen | |style="background-color: white;"|T- 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 7 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|zo nodig 2 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MA_XXX_Bourgonje /> | |}<section end=MA_XXX_Bourgonje /> | ||
Regel 896: | Regel 896: | ||
<section begin=VV_XXX_Bourgonje /> | <section begin=VV_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_123_1_VV_1 | + | |style="background-color: white;"|MBH_123_1_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 7 dagen | |style="background-color: white;"|T- 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=VV_XXX_Bourgonje /> | |}<section end=VV_XXX_Bourgonje /> | ||
Regel 929: | Regel 929: | ||
<section begin=TA_XXX_Bourgonje /> | <section begin=TA_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_123_1_TA_1 | + | |style="background-color: white;"|MBH_123_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 7 dagen | |style="background-color: white;"|T- 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 7 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|zo nodig 2 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=TA_XXX_Bourgonje /> | |}<section end=TA_XXX_Bourgonje /> | ||
Regel 975: | Regel 975: | ||
<section begin=MVE_XXX_Bourgonje /> | <section begin=MVE_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_123_1_MVE_1 | + | |style="background-color: white;"|MBH_123_1_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 7 dagen | |style="background-color: white;"|T- 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_123_1_VV_1 | |style="background-color: white;"|MBH_123_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MVE_XXX_Bourgonje /> | |}<section end=MVE_XXX_Bourgonje /> | ||
Regel 1.005: | Regel 1.005: | ||
<section begin=MGB_XXX_Bourgonje /> | <section begin=MGB_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_123_1_MGB_1 | + | |style="background-color: white;"|MBH_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2018-08-12T20:58:00 | |style="background-color: white;"|2018-08-12T20:58:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2018-08-11T00:00:00, gedurende 2 dagen | |style="background-color: white;"|Vanaf 2018-08-11T00:00:00, gedurende 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag | |style="background-color: white;"|2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MGB_XXX_Bourgonje /> | |}<section end=MGB_XXX_Bourgonje /> | ||
Regel 1.051: | Regel 1.051: | ||
<section begin=XXX_Cnossen /> | <section begin=XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|J. XXX_Cnossen | |style="background-color: white;"|J. XXX_Cnossen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911740 [BSN] | |style="background-color: white;"|999911740 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|4 aug 1964 | |style="background-color: white;"|4 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Cnossen /> | |}<section end=XXX_Cnossen /> | ||
Regel 1.075: | Regel 1.075: | ||
<section begin=MA_XXX_Cnossen /> | <section begin=MA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_1_MA_1 | + | |style="background-color: white;"|MBH_313_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 100 dagen, om 12:11 | |style="background-color: white;"|T- 100 dagen, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_1_MA_2 | + | |style="background-color: white;"|MBH_313_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 60 dagen, om 13:54 | |style="background-color: white;"|T- 60 dagen, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_2_MA_1 | + | |style="background-color: white;"|MBH_313_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 500 dagen, om 10:19 | |style="background-color: white;"|T- 500 dagen, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 500 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_2_MA_2 | + | |style="background-color: white;"|MBH_313_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 366 dagen, om 17:54 | |style="background-color: white;"|T- 366 dagen, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_3_MA_1 | + | |style="background-color: white;"|MBH_313_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 100 dagen, om 12:11 | |style="background-color: white;"|T- 100 dagen, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_3_MA_2 | + | |style="background-color: white;"|MBH_313_3_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 4 dagen, om 13:54 | |style="background-color: white;"|T- 4 dagen, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_4_MA_1 | + | |style="background-color: white;"|MBH_313_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 300 dagen, om 14:23 | |style="background-color: white;"|T- 300 dagen, om 14:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 300 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_4_MA_2 | + | |style="background-color: white;"|MBH_313_4_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 222 dagen, om 08:54 | |style="background-color: white;"|T- 222 dagen, om 08:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=MA_XXX_Cnossen /> | |}<section end=MA_XXX_Cnossen /> | ||
Regel 1.417: | Regel 1.417: | ||
<section begin=TA_XXX_Cnossen /> | <section begin=TA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_1_TA_1 | + | |style="background-color: white;"|MBH_313_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 100 dagen, om 12:11 | |style="background-color: white;"|T- 100 dagen, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_1_TA_2 | + | |style="background-color: white;"|MBH_313_1_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 60 dagen, om 13:54 | |style="background-color: white;"|T- 60 dagen, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_2_TA_1 | + | |style="background-color: white;"|MBH_313_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 500 dagen, om 10:19 | |style="background-color: white;"|T- 500 dagen, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 500 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_2_TA_2 | + | |style="background-color: white;"|MBH_313_2_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 366 dagen, om 17:54 | |style="background-color: white;"|T- 366 dagen, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_3_TA_1 | + | |style="background-color: white;"|MBH_313_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 100 dagen, om 12:30 | |style="background-color: white;"|T- 100 dagen, om 12:30 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_3_TA_2 | + | |style="background-color: white;"|MBH_313_3_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 4 dagen, om 14:54 | |style="background-color: white;"|T- 4 dagen, om 14:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_4_TA_1 | + | |style="background-color: white;"|MBH_313_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 300 dagen, om 15:23 | |style="background-color: white;"|T- 300 dagen, om 15:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 300 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_4_TA_2 | + | |style="background-color: white;"|MBH_313_4_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 222 dagen, om 09:54 | |style="background-color: white;"|T- 222 dagen, om 09:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=TA_XXX_Cnossen /> | |}<section end=TA_XXX_Cnossen /> | ||
Regel 1.765: | Regel 1.765: | ||
<section begin=MGB_XXX_Cnossen /> | <section begin=MGB_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_1_MGB_1 | + | |style="background-color: white;"|MBH_313_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2018-07-06T12:11:00 | |style="background-color: white;"|2018-07-06T12:11:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2018-07-06T00:00:00, tot nader order | |style="background-color: white;"|Vanaf 2018-07-06T00:00:00, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2018-07-06T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf 2018-07-06T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_1_MGB_2 | + | |style="background-color: white;"|MBH_313_1_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2018-06-18T15:25:00 | |style="background-color: white;"|2018-06-18T15:25:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00 | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00, Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00, Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_2_MGB_1 | + | |style="background-color: white;"|MBH_313_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2017-04-03T10:19:00 | |style="background-color: white;"|2017-04-03T10:19:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot nader order | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot nader order, Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot nader order, Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_2_MGB_2 | + | |style="background-color: white;"|MBH_313_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2017-08-15T17:54:00 | |style="background-color: white;"|2017-08-15T17:54:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00 | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00, Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00, Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_3_MGB_1 | + | |style="background-color: white;"|MBH_313_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2018-05-08T12:11:00 | |style="background-color: white;"|2018-05-08T12:11:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot nader order | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_3_MGB_2 | + | |style="background-color: white;"|MBH_313_3_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2017-08-12T13:54:00 | |style="background-color: white;"|2017-08-12T13:54:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00 | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00, Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00, Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_4_MGB_1 | + | |style="background-color: white;"|MBH_313_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2017-10-20T14:23:00 | |style="background-color: white;"|2017-10-20T14:23:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot nader order | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot nader order, Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot nader order, Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_313_4_MGB_2 | + | |style="background-color: white;"|MBH_313_4_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|2018-01-06T08:54:00 | |style="background-color: white;"|2018-01-06T08:54:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00 | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00, Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00, Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=MGB_XXX_Cnossen /> | |}<section end=MGB_XXX_Cnossen /> | ||
Regel 2.161: | Regel 2.161: | ||
<section begin=XXX_Dirksz /> | <section begin=XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|R. XXX_Dirksz | |style="background-color: white;"|R. XXX_Dirksz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911326 [BSN] | |style="background-color: white;"|999911326 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Dirksz /> | |}<section end=XXX_Dirksz /> | ||
Regel 2.185: | Regel 2.185: | ||
<section begin=MA_XXX_Dirksz /> | <section begin=MA_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_1_MA_1 | + | |style="background-color: white;"|MBH_113_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_2_MA_1 | + | |style="background-color: white;"|MBH_113_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 30 dagen, om 14:55 | |style="background-color: white;"|T- 30 dagen, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_3_MA_1 | + | |style="background-color: white;"|MBH_113_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 30 dagen, om 14:57 | |style="background-color: white;"|T- 30 dagen, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 30 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MA_XXX_Dirksz /> | |}<section end=MA_XXX_Dirksz /> | ||
Regel 2.310: | Regel 2.310: | ||
<section begin=VV_XXX_Dirksz /> | <section begin=VV_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_1_VV_1 | + | |style="background-color: white;"|MBH_113_1_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_2_VV_1 | + | |style="background-color: white;"|MBH_113_2_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 30 dagen, om 14:55 | |style="background-color: white;"|T- 30 dagen, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_3_VV_1 | + | |style="background-color: white;"|MBH_113_3_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 30 dagen, om 14:57 | |style="background-color: white;"|T- 30 dagen, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=VV_XXX_Dirksz /> | |}<section end=VV_XXX_Dirksz /> | ||
Regel 2.405: | Regel 2.405: | ||
<section begin=TA_XXX_Dirksz /> | <section begin=TA_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_1_TA_1 | + | |style="background-color: white;"|MBH_113_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_2_TA_1 | + | |style="background-color: white;"|MBH_113_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 30 dagen, om 14:55 | |style="background-color: white;"|T- 30 dagen, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_3_TA_1 | + | |style="background-color: white;"|MBH_113_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 30 dagen, om 14:57 | |style="background-color: white;"|T- 30 dagen, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 30 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=TA_XXX_Dirksz /> | |}<section end=TA_XXX_Dirksz /> | ||
Regel 2.530: | Regel 2.530: | ||
<section begin=MVE_XXX_Dirksz /> | <section begin=MVE_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_1_MVE_1 | + | |style="background-color: white;"|MBH_113_1_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 50 dagen, om 12:25 | |style="background-color: white;"|T- 50 dagen, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_113_1_VV_1 | |style="background-color: white;"|MBH_113_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_2_MVE_1 | + | |style="background-color: white;"|MBH_113_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 30 dagen, om 15:55 | |style="background-color: white;"|T- 30 dagen, om 15:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|25 stuks | |style="background-color: white;"|25 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Zestril tablet 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Zestril tablet 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_113_2_VV_1 | |style="background-color: white;"|MBH_113_2_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_3_MVE_1 | + | |style="background-color: white;"|MBH_113_3_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 30 dagen, om 15:56 | |style="background-color: white;"|T- 30 dagen, om 15:56 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_113_3_VV_1 | |style="background-color: white;"|MBH_113_3_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MVE_XXX_Dirksz /> | |}<section end=MVE_XXX_Dirksz /> | ||
Regel 2.616: | Regel 2.616: | ||
<section begin=MGB_XXX_Dirksz /> | <section begin=MGB_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_1_MGB_1 | + | |style="background-color: white;"|MBH_113_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 48 dagen, om 11:25 | |style="background-color: white;"|T- 48 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag | |style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_2_MGB_1 | + | |style="background-color: white;"|MBH_113_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 13 dagen, om 14:55 | |style="background-color: white;"|T- 13 dagen, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_113_3_MGB_1 | + | |style="background-color: white;"|MBH_113_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 29 dagen, om 14:57 | |style="background-color: white;"|T- 29 dagen, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MGB_XXX_Dirksz /> | |}<section end=MGB_XXX_Dirksz /> | ||
Regel 2.762: | Regel 2.762: | ||
<section begin=XXX_Gobee /> | <section begin=XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|R. XXX_Gobee | |style="background-color: white;"|R. XXX_Gobee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911314 [BSN] | |style="background-color: white;"|999911314 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Gobee /> | |}<section end=XXX_Gobee /> | ||
Regel 2.786: | Regel 2.786: | ||
<section begin=MA_XXX_Gobee /> | <section begin=MA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MA_1 | + | |style="background-color: white;"|MBH_213_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | + | |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MA_2 | + | |style="background-color: white;"|MBH_213_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 40 dagen, om 09:13 | |style="background-color: white;"|T- 40 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = ' | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49485' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | + | |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MA_3 | + | |style="background-color: white;"|MBH_213_1_MA_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 40 dagen, om 09:13 | |style="background-color: white;"|T- 40 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |style="background-color: white;"|Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MA_4 | + | |style="background-color: white;"|MBH_213_1_MA_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 15 dagen, om 09:13 | |style="background-color: white;"|T- 15 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MA_5 | + | |style="background-color: white;"|MBH_213_1_MA_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 15 dagen, om 16:25 | |style="background-color: white;"|T- 15 dagen, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Wens patiënt (code = '12' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |style="background-color: white;"|Wens patiënt (code = '12' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MA_XXX_Gobee /> | |}<section end=MA_XXX_Gobee /> | ||
Regel 3.005: | Regel 3.005: | ||
<section begin=VV_XXX_Gobee /> | <section begin=VV_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_VV_1 | + | |style="background-color: white;"|MBH_213_1_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aantal herhalingen |
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_VV_2 | + | |style="background-color: white;"|MBH_213_1_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 40 dagen, om 09:13 | |style="background-color: white;"|T- 40 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aantal herhalingen |
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_VV_3 | + | |style="background-color: white;"|MBH_213_1_VV_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 15 dagen, om 16:25 | |style="background-color: white;"|T- 15 dagen, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verbruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=VV_XXX_Gobee /> | |}<section end=VV_XXX_Gobee /> | ||
Regel 3.106: | Regel 3.106: | ||
<section begin=TA_XXX_Gobee /> | <section begin=TA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_TA_1 | + | |style="background-color: white;"|MBH_213_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | + | |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_TA_2 | + | |style="background-color: white;"|MBH_213_1_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 40 dagen, om 09:13 | |style="background-color: white;"|T- 40 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | + | |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_TA_3 | + | |style="background-color: white;"|MBH_213_1_TA_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 40 dagen, om 09:13 | |style="background-color: white;"|T- 40 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_TA_4 | + | |style="background-color: white;"|MBH_213_1_TA_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 15 dagen, om 09:13 | |style="background-color: white;"|T- 15 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_TA_5 | + | |style="background-color: white;"|MBH_213_1_TA_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 15 dagen, om 16:25 | |style="background-color: white;"|T- 15 dagen, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=TA_XXX_Gobee /> | |}<section end=TA_XXX_Gobee /> | ||
Regel 3.319: | Regel 3.319: | ||
<section begin=MVE_XXX_Gobee /> | <section begin=MVE_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MVE_1 | + | |style="background-color: white;"|MBH_213_1_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 50 dagen, om 13:25 | |style="background-color: white;"|T- 50 dagen, om 13:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_213_1_VV_1 | |style="background-color: white;"|MBH_213_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MVE_2 | + | |style="background-color: white;"|MBH_213_1_MVE_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 40 dagen, om 09:13 | |style="background-color: white;"|T- 40 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MVE_3 | + | |style="background-color: white;"|MBH_213_1_MVE_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T- 15 dagen, om 17:25 | |style="background-color: white;"|T- 15 dagen, om 17:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verbruiksduur |
|style="background-color: white;"|30 dagen | |style="background-color: white;"|30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MVE_XXX_Gobee /> | |}<section end=MVE_XXX_Gobee /> | ||
Regel 3.408: | Regel 3.408: | ||
<section begin=MGB_XXX_Gobee /> | <section begin=MGB_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MGB_1 | + | |style="background-color: white;"|MBH_213_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 47 dagen, om 11:25 | |style="background-color: white;"|T- 47 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MGB_2 | + | |style="background-color: white;"|MBH_213_1_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 41 dagen, om 11:25 | |style="background-color: white;"|T- 41 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen | |style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MGB_3 | + | |style="background-color: white;"|MBH_213_1_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 35 dagen, om 19:25 | |style="background-color: white;"|T- 35 dagen, om 19:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : TA |
|style="background-color: white;"|MBH_213_1_TA_3 | |style="background-color: white;"|MBH_213_1_TA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MGB_4 | + | |style="background-color: white;"|MBH_213_1_MGB_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 16 dagen, om 11:25 | |style="background-color: white;"|T- 16 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen | |style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_213_1_MGB_5 | + | |style="background-color: white;"|MBH_213_1_MGB_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 10 dagen, om 11:25 | |style="background-color: white;"|T- 10 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MGB_XXX_Gobee /> | |}<section end=MGB_XXX_Gobee /> | ||
Regel 3.642: | Regel 3.642: | ||
<section begin=XXX_Kilkenny /> | <section begin=XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|J. XXX_Kilkenny | |style="background-color: white;"|J. XXX_Kilkenny | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911752 [BSN] | |style="background-color: white;"|999911752 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|5 aug 1964 | |style="background-color: white;"|5 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Kilkenny /> | |}<section end=XXX_Kilkenny /> | ||
Regel 3.666: | Regel 3.666: | ||
<section begin=MA_XXX_Kilkenny /> | <section begin=MA_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_323_1_MA_1 | + | |style="background-color: white;"|MBH_323_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 5 dagen, om 15:34 | |style="background-color: white;"|T- 5 dagen, om 15:34 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Stoptype |
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59, 3x per dag 1 tablet | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59, 3x per dag 1 tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_323_1 | |style="background-color: white;"|MBH_323_1 | ||
|}<section end=MA_XXX_Kilkenny /> | |}<section end=MA_XXX_Kilkenny /> | ||
Regel 3.709: | Regel 3.709: | ||
<section begin=MGB_XXX_Kilkenny /> | <section begin=MGB_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_323_1_MGB_1 | + | |style="background-color: white;"|MBH_323_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 10 dagen, om 11:25 | |style="background-color: white;"|T- 10 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, tot nader order | |style="background-color: white;"|Vanaf T- 20 dagen, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, tot nader order, 3x per dag 1 tablet | |style="background-color: white;"|Vanaf T- 20 dagen, tot nader order, 3x per dag 1 tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_323_1 | |style="background-color: white;"|MBH_323_1 | ||
|}<section end=MGB_XXX_Kilkenny /> | |}<section end=MGB_XXX_Kilkenny /> | ||
Regel 3.752: | Regel 3.752: | ||
<section begin=XXX_Ruys /> | <section begin=XXX_Ruys /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|R. XXX_Ruys | |style="background-color: white;"|R. XXX_Ruys | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911351 [BSN] | |style="background-color: white;"|999911351 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Ruys /> | |}<section end=XXX_Ruys /> | ||
Regel 3.776: | Regel 3.776: | ||
<section begin=XXX_Strengersz /> | <section begin=XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Naamgegevens |
|style="background-color: white;"|R. XXX_Strengersz | |style="background-color: white;"|R. XXX_Strengersz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|999911338 [BSN] | |style="background-color: white;"|999911338 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Patient identificatienummer |
|style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | ||
|}<section end=XXX_Strengersz /> | |}<section end=XXX_Strengersz /> | ||
Regel 3.800: | Regel 3.800: | ||
<section begin=MA_XXX_Strengersz /> | <section begin=MA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_1_MA_1 | + | |style="background-color: white;"|MBH_413_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_2_MA_1 | + | |style="background-color: white;"|MBH_413_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|exact iedere 3 uur 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_3_MA_1 | + | |style="background-color: white;"|MBH_413_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_4_MA_1 | + | |style="background-color: white;"|MBH_413_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 20 dagen, om 10:26 | |style="background-color: white;"|T- 20 dagen, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_5_MA_1 | + | |style="background-color: white;"|MBH_413_5_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 20 dagen, om 10:46 | |style="background-color: white;"|T- 20 dagen, om 10:46 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_6_MA_1 | + | |style="background-color: white;"|MBH_413_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_7_MA_1 | + | |style="background-color: white;"|MBH_413_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_8_MA_1 | + | |style="background-color: white;"|MBH_413_8_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 10 weken | |style="background-color: white;"|Vanaf T, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | |style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_9_MA_1 | + | |style="background-color: white;"|MBH_413_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_10_MA_1 | + | |style="background-color: white;"|MBH_413_10_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Herhaalperiode cyclisch schema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_11_MA_1 | + | |style="background-color: white;"|MBH_413_11_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 41 dagen | |style="background-color: white;"|Vanaf T, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 1 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 2 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 3 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_12_MA_1 | + | |style="background-color: white;"|MBH_413_12_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 3 weken | |style="background-color: white;"|Vanaf T, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|bij hoest 3 à 4 maal per uur 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_13_MA_1 | + | |style="background-color: white;"|MBH_413_13_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 28 dagen, om 09:12 | |style="background-color: white;"|T- 28 dagen, om 09:12 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|0.5 ml per uur | |style="background-color: white;"|0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_13_MA_2 | + | |style="background-color: white;"|MBH_413_13_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 20 dagen, om 11:25 | |style="background-color: white;"|T- 20 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|0.2 à 0.5 ml per uur | |style="background-color: white;"|0.2 à 0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_14_MA_1 | + | |style="background-color: white;"|MBH_413_14_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_15_MA_1 | + | |style="background-color: white;"|MBH_413_15_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 4 dagen | |style="background-color: white;"|Vanaf T, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="16"| | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Product naam |
|style="background-color: white;"|Haparine 100 ie= 10 ml | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|100 internationale eenheid per 10 ml | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|1 stuk per 10 ml | + | |style="background-color: white;"|1 stuk per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|0.09 gram per 10 ml | + | |style="background-color: white;"|0.09 gram per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | |style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MA_XXX_Strengersz /> | |}<section end=MA_XXX_Strengersz /> | ||
Regel 4.522: | Regel 4.522: | ||
<section begin=VV_XXX_Strengersz /> | <section begin=VV_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_15_VV_1 | + | |style="background-color: white;"|MBH_413_15_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Te verstrekken hoeveelheid |
|style="background-color: white;"|100 ml | |style="background-color: white;"|100 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Aantal herhalingen |
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="16"| | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Product naam |
|style="background-color: white;"|Haparine 100 ie= 10 ml | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|100 internationale eenheid per 10 ml | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|1 stuk per 10 ml | + | |style="background-color: white;"|1 stuk per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|0.09 gram per 10 ml | + | |style="background-color: white;"|0.09 gram per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=VV_XXX_Strengersz /> | |}<section end=VV_XXX_Strengersz /> | ||
Regel 4.598: | Regel 4.598: | ||
<section begin=TA_XXX_Strengersz /> | <section begin=TA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_1_TA_1 | + | |style="background-color: white;"|MBH_413_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_2_TA_1 | + | |style="background-color: white;"|MBH_413_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|exact iedere 3 uur 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_3_TA_1 | + | |style="background-color: white;"|MBH_413_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 50 dagen, om 11:25 | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_4_TA_1 | + | |style="background-color: white;"|MBH_413_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 20 dagen, om 10:26 | |style="background-color: white;"|T- 20 dagen, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_5_TA_1 | + | |style="background-color: white;"|MBH_413_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 20 dagen, om 10:46 | |style="background-color: white;"|T- 20 dagen, om 10:46 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_6_TA_1 | + | |style="background-color: white;"|MBH_413_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_7_TA_1 | + | |style="background-color: white;"|MBH_413_7_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_8_TA_1 | + | |style="background-color: white;"|MBH_413_8_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 10 weken | |style="background-color: white;"|Vanaf T, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | |style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_9_TA_1 | + | |style="background-color: white;"|MBH_413_9_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_10_TA_1 | + | |style="background-color: white;"|MBH_413_10_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Herhaalperiode cyclisch schema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_11_TA_1 | + | |style="background-color: white;"|MBH_413_11_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 41 dagen | |style="background-color: white;"|Vanaf T, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|FUCIDIN CREME 20MG/G (code = '420956' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|FUCIDIN CREME 20MG/G (code = '420956' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 1 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 2 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 3 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_12_TA_1 | + | |style="background-color: white;"|MBH_413_12_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 3 weken | |style="background-color: white;"|Vanaf T, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|bij hoest 3 à 4 maal per uur 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_13_TA_1 | + | |style="background-color: white;"|MBH_413_13_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 28 dagen, om 09:12 | |style="background-color: white;"|T- 28 dagen, om 09:12 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|0.5 ml per uur | |style="background-color: white;"|0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_13_MA_1 | |style="background-color: white;"|MBH_413_13_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_13_TA_2 | + | |style="background-color: white;"|MBH_413_13_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T- 20 dagen, om 11:25 | |style="background-color: white;"|T- 20 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|0.2 à 0.5 ml per uur | |style="background-color: white;"|0.2 à 0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_13_MA_2 | |style="background-color: white;"|MBH_413_13_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_14_TA_1 | + | |style="background-color: white;"|MBH_413_14_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 11:25 | |style="background-color: white;"|T, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf 2018-08-16T00:00:00, tot nader order | |style="background-color: white;"|Vanaf 2018-08-16T00:00:00, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf 2018-08-16T00:00:00, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | |style="background-color: white;"|Vanaf 2018-08-16T00:00:00, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_15_TA_1 | + | |style="background-color: white;"|MBH_413_15_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Afspraakdatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 4 dagen | |style="background-color: white;"|Vanaf T, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="16"| | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Product naam |
|style="background-color: white;"|Haparine 100 ie= 10 ml | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|100 internationale eenheid per 10 ml | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|1 stuk per 10 ml | + | |style="background-color: white;"|1 stuk per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|0.09 gram per 10 ml | + | |style="background-color: white;"|0.09 gram per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | |style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=TA_XXX_Strengersz /> | |}<section end=TA_XXX_Strengersz /> | ||
Regel 5.323: | Regel 5.323: | ||
<section begin=MVE_XXX_Strengersz /> | <section begin=MVE_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_9_MVE_1 | + | |style="background-color: white;"|MBH_413_9_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T, om 10:35 | |style="background-color: white;"|T, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Distributievorm |
|style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | |style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_15_MVE_1 | + | |style="background-color: white;"|MBH_413_15_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Datum |
|style="background-color: white;"|T, om 10:35 | |style="background-color: white;"|T, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Verstrekte hoeveelheid |
|style="background-color: white;"|100 ml | |style="background-color: white;"|100 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="16"| | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Product naam |
|style="background-color: white;"|Haparine 100 ie= 10 ml | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|100 internationale eenheid per 10 ml | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|1 stuk per 10 ml | + | |style="background-color: white;"|1 stuk per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|0.09 gram per 10 ml | + | |style="background-color: white;"|0.09 gram per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_513_15_VV_1 | |style="background-color: white;"|MBH_513_15_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MVE_XXX_Strengersz /> | |}<section end=MVE_XXX_Strengersz /> | ||
Regel 5.421: | Regel 5.421: | ||
<section begin=MGB_XXX_Strengersz /> | <section begin=MGB_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_1_MGB_1 | + | |style="background-color: white;"|MBH_413_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 16:25 | |style="background-color: white;"|T, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_2_MGB_1 | + | |style="background-color: white;"|MBH_413_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 14:25 | |style="background-color: white;"|T, om 14:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen | |style="background-color: white;"|Vanaf T, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|exact iedere 3 uur 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_3_MGB_1 | + | |style="background-color: white;"|MBH_413_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 10:45 | |style="background-color: white;"|T, om 10:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_4_MGB_1 | + | |style="background-color: white;"|MBH_413_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T- 15 dagen, om 13:44 | |style="background-color: white;"|T- 15 dagen, om 13:44 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59 | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_5_MGB_1 | + | |style="background-color: white;"|MBH_413_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 12:38 | |style="background-color: white;"|T, om 12:38 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_6_MGB_1 | + | |style="background-color: white;"|MBH_413_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 21:37 | |style="background-color: white;"|T, om 21:37 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 1 dag | |style="background-color: white;"|Vanaf T, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_7_MGB_1 | + | |style="background-color: white;"|MBH_413_7_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 14:05 | |style="background-color: white;"|T, om 14:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, om 14:00, tot en met T, om 14:05 | |style="background-color: white;"|Vanaf T, om 14:00, tot en met T, om 14:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, om 14:00, tot en met T, om 14:05, om 14:00 16IE | |style="background-color: white;"|Vanaf T, om 14:00, tot en met T, om 14:05, om 14:00 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_7_MGB_2 | + | |style="background-color: white;"|MBH_413_7_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 20:10 | |style="background-color: white;"|T, om 20:10 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, om 20:00, tot en met T, om 20:05 | |style="background-color: white;"|Vanaf T, om 20:00, tot en met T, om 20:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, om 20:00, tot en met T, om 20:05, om 20:00 16IE | |style="background-color: white;"|Vanaf T, om 20:00, tot en met T, om 20:05, om 20:00 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_8_MGB_1 | + | |style="background-color: white;"|MBH_413_8_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 23:59 | |style="background-color: white;"|T, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 10 weken | |style="background-color: white;"|Vanaf T, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | |style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_9_MGB_1 | + | |style="background-color: white;"|MBH_413_9_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 22:35 | |style="background-color: white;"|T, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_10_MGB_1 | + | |style="background-color: white;"|MBH_413_10_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 09:35 | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Herhaalperiode cyclisch schema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_11_MGB_1 | + | |style="background-color: white;"|MBH_413_11_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 15:35 | |style="background-color: white;"|T, om 15:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 41 dagen | |style="background-color: white;"|Vanaf T, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie 1 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_12_MGB_1 | + | |style="background-color: white;"|MBH_413_12_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 22:35 | |style="background-color: white;"|T, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 3 weken | |style="background-color: white;"|Vanaf T, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|bij hoest 3 à 4 maal per uur 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_14_MGB_1 | + | |style="background-color: white;"|MBH_413_14_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 22:35 | |style="background-color: white;"|T, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Geneesmiddel |
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="10" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="9" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Identificatie |
− | |style="background-color: white;"|MBH_413_15_MGB_1 | + | |style="background-color: white;"|MBH_413_15_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Registratiedatum |
|style="background-color: white;"|T, om 10:35 | |style="background-color: white;"|T, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gebruiksperiode |
|style="background-color: white;"|Vanaf T, gedurende 4 dagen | |style="background-color: white;"|Vanaf T, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Voorschrijver |
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="16"| | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Product naam |
|style="background-color: white;"|Haparine 100 ie= 10 ml | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
− | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|100 internationale eenheid per 10 ml | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|1 stuk per 10 ml | + | |style="background-color: white;"|1 stuk per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Ingredient code | + | |colspan="7"|Ingredient code |
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Sterkte | + | |colspan="7"|Sterkte |
− | |style="background-color: white;"|0.09 gram per 10 ml | + | |style="background-color: white;"|0.09 gram per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="10"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | |style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="8"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Gerelateerde afspraak : MA |
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="9"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MGB_XXX_Strengersz /> | |}<section end=MGB_XXX_Strengersz /> |
Versie van 8 okt 2018 om 15:37
Deze pagina is nog in bewerking |
Inhoud
Addenda voor inhoudelijke gegevens
Patiënt J. XXX_Amaya
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | J. XXX_Amaya | ||||||||
Patient identificatienummer | 999911764 [BSN] | ||||||||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 6 aug 1964 | ||||||||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Amaya
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 1 dag, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||||||||
Geannuleerd indicator | true | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 10 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:00 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 14:32 | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||||||||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||||||||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 14:32 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||||||||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||||||||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||||||||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||||||||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per week 5 stuks | ||||||||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 5 dagen, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 3 maal per dag 1 stuk | ||||||||
Lichaamslengte | 155 | ||||||||
Lichaamsgewicht | 54 | ||||||||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||||||||
Toelichting | In overleg met specialist | ||||||||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Amaya
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | 2018-08-16T14:32:00 | ||||||||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||||||||
Te verstrekken hoeveelheid | 30 stuks | ||||||||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Toelichting | nog in te vullen, zie word... | ||||||||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||||||||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 5 dagen, om 09:35 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 40 stuks | ||||||||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Afleverlocatie | Huisadres patiënt | ||||||||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||||||||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||||||||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Amaya
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 12:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Geannuleerd indicator | true | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||||||||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 7 dagen, om 14:52 | ||||||||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Reden afspraak | Opname | ||||||||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||||||||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 5 dagen, om 09:45 | ||||||||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 3 maal per dag 1 stuk | ||||||||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||||||||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||||||||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||||||||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Amaya
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Aanschrijfdatum | T, om 14:32 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 30 stuks | ||||||||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||||||||
MBH identificatie | MBH_513_2 |
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 5 dagen, om 09:45 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 30 stuks | ||||||||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||||||||
Afleverlocatie | Huisadres patiënt | ||||||||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||||||||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||||||||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||||||||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Amaya
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 2 dagen, om 15:39 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||||||||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||||||||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 20:40 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||||||||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||||||||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||||||||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 21:39 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||||||||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 20:59 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||||||||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 3 dagen, om 20:59 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||||||||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||||||||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||||||||
Doseerinstructie | 1 maal per week 5 stuks | ||||||||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
Reden gebruik | Lymfekanker | ||||||||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 4 dagen, om 22:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | false | ||||||||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||||||||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_513_4 |
Patiënt Pauline P. XXX_Bourgonje
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | Pauline P. XXX_Bourgonje | ||||||||
Patient identificatienummer | 999911296 [BSN] | ||||||||
Patient identificatienummer | 12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 1 aug 1964 | ||||||||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Bourgonje
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_123_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 7 dagen | ||||||||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||||||||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | ||||||||
Toedieningsweg | Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | zo nodig 2 maal per dag | ||||||||
MBH identificatie | MBH_123_1 |
Verstrekkingsverzoeken XXX_Bourgonje
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_123_1_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 7 dagen | ||||||||
Auteur | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||||||||
Te verstrekken hoeveelheid | 100 gram | ||||||||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||||||||
MBH identificatie | MBH_123_1 |
Toedieningsafspraken XXX_Bourgonje
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_123_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 7 dagen | ||||||||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | ||||||||
Toedieningsweg | Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | zo nodig 2 maal per dag | ||||||||
Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||||||||
MBH identificatie | MBH_123_1 |
Verstrekkingen XXX_Bourgonje
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_123_1_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 7 dagen | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 100 gram | ||||||||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_123_1_VV_1 | ||||||||
MBH identificatie | MBH_123_1 |
Medicatiegebruik XXX_Bourgonje
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2018-08-12T20:58:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2018-08-11T00:00:00, gedurende 2 dagen | ||||||||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||||||||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 2 maal per dag | ||||||||
Gerelateerde afspraak : MA | MBH_123_1_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_123_1 |
Patiënt J. XXX_Cnossen
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | J. XXX_Cnossen | ||||||||
Patient identificatienummer | 999911740 [BSN] | ||||||||
Patient identificatienummer | 31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 4 aug 1964 | ||||||||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Cnossen
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 100 dagen, om 12:11 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||||||||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 dosis | ||||||||
MBH identificatie | MBH_313_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 60 dagen, om 13:54 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||||||||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | ||||||||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 dosis | ||||||||
MBH identificatie | MBH_313_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 500 dagen, om 10:19 | ||||||||
Gebruiksperiode | Vanaf T- 500 dagen, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | ||||||||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Aanvullende instructie | in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie | 1 maal per dag 1 druppel | ||||||||
MBH identificatie | MBH_313_2 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 366 dagen, om 17:54 | ||||||||
Gebruiksperiode | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||||||||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | ||||||||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Aanvullende instructie | in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie | 1 maal per dag 1 druppel | ||||||||
MBH identificatie | MBH_313_2 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 100 dagen, om 12:11 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_313_3 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_3_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 4 dagen, om 13:54 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | ||||||||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_313_3 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 300 dagen, om 14:23 | ||||||||
Gebruiksperiode | Vanaf T- 300 dagen, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_313_4 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_4_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 222 dagen, om 08:54 | ||||||||
Gebruiksperiode | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | ||||||||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_313_4 |
Toedieningsafspraken XXX_Cnossen
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 100 dagen, om 12:11 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||||||||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 dosis | ||||||||
Relatie naar medicatieafspraak | MBH_313_1_MA_1 | ||||||||
MBH identificatie | MBH_313_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_1_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 60 dagen, om 13:54 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | ||||||||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 dosis | ||||||||
Relatie naar medicatieafspraak | MBH_313_1_MA_2 | ||||||||
MBH identificatie | MBH_313_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 500 dagen, om 10:19 | ||||||||
Gebruiksperiode | Vanaf T- 500 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | ||||||||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Aanvullende instructie | in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie | 1 maal per dag 1 druppel | ||||||||
Relatie naar medicatieafspraak | MBH_313_2_MA_1 | ||||||||
MBH identificatie | MBH_313_2 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_2_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 366 dagen, om 17:54 | ||||||||
Gebruiksperiode | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | ||||||||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Aanvullende instructie | in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie | 1 maal per dag 1 druppel | ||||||||
Relatie naar medicatieafspraak | MBH_313_2_MA_2 | ||||||||
MBH identificatie | MBH_313_2 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 100 dagen, om 12:30 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_313_3_MA_1 | ||||||||
MBH identificatie | MBH_313_3 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_3_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 4 dagen, om 14:54 | ||||||||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | ||||||||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_313_3_MA_2 | ||||||||
MBH identificatie | MBH_313_3 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 300 dagen, om 15:23 | ||||||||
Gebruiksperiode | Vanaf T- 300 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_313_4_MA_1 | ||||||||
MBH identificatie | MBH_313_4 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_4_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 222 dagen, om 09:54 | ||||||||
Gebruiksperiode | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | ||||||||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_313_4_MA_2 | ||||||||
MBH identificatie | MBH_313_4 |
Medicatiegebruik XXX_Cnossen
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2018-07-06T12:11:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2018-07-06T00:00:00, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2018-07-06T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||||||||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 dosis | ||||||||
Gerelateerde afspraak : MA | MBH_313_1_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_1_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2018-06-18T15:25:00 | ||||||||
Gebruik indicator | false | ||||||||
Gebruiksperiode | Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00, Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||||||||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 dosis | ||||||||
Gerelateerde afspraak : MA | MBH_313_1_MA_2 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2017-04-03T10:19:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2017-04-03T00:00:00, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2017-04-03T00:00:00, tot nader order, Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||||||||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Aanvullende instructie | in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie | 1 maal per dag 1 druppel | ||||||||
Gerelateerde afspraak : MA | MBH_313_2_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2017-08-15T17:54:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00, Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||||||||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Aanvullende instructie | in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie | 1 maal per dag 1 druppel | ||||||||
Gerelateerde afspraak : MA | MBH_313_2_MA_2 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2018-05-08T12:11:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2018-05-08T00:00:00, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2018-05-08T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_313_3_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_3 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_3_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2017-08-12T13:54:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00 | ||||||||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00, Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_313_3_MA_2 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_3 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2017-10-20T14:23:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2017-10-20T00:00:00, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2017-10-20T00:00:00, tot nader order, Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_313_4_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_4 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_313_4_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | 2018-01-06T08:54:00 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00 | ||||||||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00, Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_313_4_MA_2 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_313_4 |
Patiënt R. XXX_Dirksz
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | R. XXX_Dirksz | ||||||||
Patient identificatienummer | 999911326 [BSN] | ||||||||
Patient identificatienummer | 11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 1 aug 1964 | ||||||||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Dirksz
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 50 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 30 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||||||||
Toedieningsweg | Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | zo nodig 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_113_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 30 dagen, om 14:55 | ||||||||
Gebruiksperiode | Vanaf T- 30 dagen, gedurende 3 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_113_2 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 30 dagen, om 14:57 | ||||||||
Gebruiksperiode | Vanaf T- 30 dagen, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_113_3 |
Verstrekkingsverzoeken XXX_Dirksz
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_1_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 50 dagen, om 11:25 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 30 stuks | ||||||||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||||||||
MBH identificatie | MBH_113_1 |
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_2_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 30 dagen, om 14:55 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 21 stuks | ||||||||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||||||||
MBH identificatie | MBH_113_2 |
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_3_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 30 dagen, om 14:57 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 21 stuks | ||||||||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_113_3_MA_1 | ||||||||
MBH identificatie | MBH_113_3 |
Toedieningsafspraken XXX_Dirksz
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 50 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 30 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||||||||
Toedieningsweg | Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | zo nodig 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||||||||
MBH identificatie | MBH_113_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 30 dagen, om 14:55 | ||||||||
Gebruiksperiode | Vanaf T- 30 dagen, gedurende 3 weken | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||||||||
MBH identificatie | MBH_113_2 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 30 dagen, om 14:57 | ||||||||
Gebruiksperiode | Vanaf T- 30 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||||||||
MBH identificatie | MBH_113_3 |
Verstrekkingen XXX_Dirksz
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_1_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 50 dagen, om 12:25 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 30 stuks | ||||||||
Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_113_1_VV_1 | ||||||||
MBH identificatie | MBH_113_1 |
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 30 dagen, om 15:55 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 25 stuks | ||||||||
Geneesmiddel | Zestril tablet 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_113_2_VV_1 | ||||||||
MBH identificatie | MBH_113_2 |
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_3_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 30 dagen, om 15:56 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 21 stuks | ||||||||
Geneesmiddel | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_113_3_VV_1 | ||||||||
MBH identificatie | MBH_113_3 |
Medicatiegebruik XXX_Dirksz
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 48 dagen, om 11:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 48 dagen, gedurende 1 dag | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 48 dagen, gedurende 1 dag, zo nodig 1 maal per dag 1 stuk, rectaal | ||||||||
Toedieningsweg | Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | zo nodig 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_113_1_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_113_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 13 dagen, om 14:55 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 30 dagen, gedurende 3 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_113_2_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_113_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_113_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 29 dagen, om 14:57 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_113_3_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_113_3 |
Patiënt R. XXX_Gobee
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | R. XXX_Gobee | ||||||||
Patient identificatienummer | 999911314 [BSN] | ||||||||
Patient identificatienummer | 21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 1 aug 1964 | ||||||||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Gobee
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 50 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | zo nodig 1 à 2 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 40 dagen, om 09:13 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_1 | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49485' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | zo nodig 1 à 2 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MA_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 40 dagen, om 09:13 | ||||||||
Gebruiksperiode | Vanaf T- 40 dagen, gedurende 30 dagen | ||||||||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_2 | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MA_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 15 dagen, om 09:13 | ||||||||
Gebruiksperiode | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_3 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MA_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 15 dagen, om 16:25 | ||||||||
Gebruiksperiode | Vanaf T- 14 dagen, gedurende 30 dagen | ||||||||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_4 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Wens patiënt (code = '12' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoeken XXX_Gobee
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 50 dagen, om 11:25 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 40 stuks | ||||||||
Aantal herhalingen | 1 | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||||||||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 40 dagen, om 09:13 | ||||||||
Auteur | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 60 stuks | ||||||||
Aantal herhalingen | 1 | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||||||||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_VV_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T- 15 dagen, om 16:25 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Verbruiksperiode | tot nader order | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||||||||
MBH identificatie | MBH_213_1 |
Toedieningsafspraken XXX_Gobee
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 50 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | zo nodig 1 à 2 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||||||||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 40 dagen, om 09:13 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | zo nodig 1 à 2 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_2 | ||||||||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_TA_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 40 dagen, om 09:13 | ||||||||
Gebruiksperiode | Vanaf T- 40 dagen, gedurende 30 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||||||||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_TA_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 15 dagen, om 09:13 | ||||||||
Gebruiksperiode | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_4 | ||||||||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_TA_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 15 dagen, om 16:25 | ||||||||
Gebruiksperiode | Vanaf T- 14 dagen, gedurende 30 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||||||||
MBH identificatie | MBH_213_1 |
Verstrekkingen XXX_Gobee
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 50 dagen, om 13:25 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 40 stuks | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_1 | ||||||||
MBH identificatie | MBH_213_1 |
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MVE_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 40 dagen, om 09:13 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 60 stuks | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||||||||
MBH identificatie | MBH_213_1 |
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MVE_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T- 15 dagen, om 17:25 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 30 stuks | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||||||||
Verbruiksduur | 30 dagen | ||||||||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||||||||
MBH identificatie | MBH_213_1 |
Medicatiegebruik XXX_Gobee
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 47 dagen, om 11:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 3 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_213_1_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 41 dagen, om 11:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 46 dagen, gedurende 6 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 46 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_213_1_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 35 dagen, om 19:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 40 dagen, gedurende 6 dagen | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 40 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : TA | MBH_213_1_TA_3 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MGB_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 16 dagen, om 11:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 34 dagen, gedurende 19 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 34 dagen, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_213_1_MA_3 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_213_1_MGB_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 10 dagen, om 11:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 14 dagen, gedurende 5 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 14 dagen, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_213_1_MA_5 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_213_1 |
Patiënt J. XXX_Kilkenny
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | J. XXX_Kilkenny | ||||||||
Patient identificatienummer | 999911752 [BSN] | ||||||||
Patient identificatienummer | 22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 5 aug 1964 | ||||||||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Kilkenny
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_323_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 5 dagen, om 15:34 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59 | ||||||||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||||||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59, 3x per dag 1 tablet | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 3 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_323_1 |
Medicatiegebruik XXX_Kilkenny
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_323_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 10 dagen, om 11:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, tot nader order | ||||||||
Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, tot nader order, 3x per dag 1 tablet | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||||||
Doseerinstructie | 3 maal per dag 1 stuk | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_323_1 |
Patiënt R. XXX_Ruys
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | R. XXX_Ruys | ||||||||
Patient identificatienummer | 999911351 [BSN] | ||||||||
Patient identificatienummer | 13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 1 aug 1964 | ||||||||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Patiënt R. XXX_Strengersz
Patiënt | |||||||||
Gegevenselement | Waarde | ||||||||
Naamgegevens | R. XXX_Strengersz | ||||||||
Patient identificatienummer | 999911338 [BSN] | ||||||||
Patient identificatienummer | 41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||||||||
Geboortedatum | 1 aug 1964 | ||||||||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Strengersz
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||||||||
MBH identificatie | MBH_413_1 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | exact iedere 3 uur 16 internationale eenheid | ||||||||
MBH identificatie | MBH_413_2 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 50 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||||||||
MBH identificatie | MBH_413_3 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 20 dagen, om 10:26 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||||||||
Toedieningsweg | cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 3 maal per dag | ||||||||
MBH identificatie | MBH_413_4 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_5_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 20 dagen, om 10:46 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||||||||
MBH identificatie | MBH_413_5 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||||||||
Toedieningsweg | niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||||||||
MBH identificatie | MBH_413_6 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||||||||
MBH identificatie | MBH_413_7 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_8_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 10 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | op maandag, woensdag en vrijdag | ||||||||
MBH identificatie | MBH_413_8 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||||||||
MBH identificatie | MBH_413_9 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_10_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||||||||
Herhaalperiode cyclisch schema | 28 dagen | ||||||||
MBH identificatie | MBH_413_10 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_11_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 41 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||||||||
Toedieningsweg | cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||||||||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||||||||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||||||||
MBH identificatie | MBH_413_11 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_12_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | bij hoest 3 à 4 maal per uur 1 stuk | ||||||||
MBH identificatie | MBH_413_12 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_13_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 28 dagen, om 09:12 | ||||||||
Gebruiksperiode | Vanaf T- 28 dagen, gedurende 8 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 0.5 ml per uur | ||||||||
MBH identificatie | MBH_413_13 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_13_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T- 20 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 8 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 0.2 à 0.5 ml per uur | ||||||||
MBH identificatie | MBH_413_13 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_14_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||||||||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||||||||
MBH identificatie | MBH_413_14 |
Medicatieafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_15_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 4 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||||||||
Geneesmiddel - Product specificatie | |||||||||
Product naam | Haparine 100 ie= 10 ml | ||||||||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||||||||
Farmaceutische vorm | vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||||||||
Ingredient | |||||||||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 100 internationale eenheid per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 1 stuk per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 0.09 gram per 10 ml | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 10 ml | ||||||||
MBH identificatie | MBH_413_15 |
Verstrekkingsverzoeken XXX_Strengersz
Verstrekkingsverzoek | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_15_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||||||
Datum | T, om 09:35 | ||||||||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Te verstrekken hoeveelheid | 100 ml | ||||||||
Aantal herhalingen | 1 | ||||||||
Geneesmiddel - Product specificatie | |||||||||
Product naam | Haparine 100 ie= 10 ml | ||||||||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||||||||
Farmaceutische vorm | vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||||||||
Ingredient | |||||||||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 100 internationale eenheid per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 1 stuk per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 0.09 gram per 10 ml | ||||||||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||||||||
Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||||||||
MBH identificatie | MBH_413_15 |
Toedieningsafspraken XXX_Strengersz
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_413_1_MA_1 | ||||||||
MBH identificatie | MBH_413_1 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | exact iedere 3 uur 16 internationale eenheid | ||||||||
Relatie naar medicatieafspraak | MBH_413_2_MA_1 | ||||||||
MBH identificatie | MBH_413_2 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 50 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 weken | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||||||||
Relatie naar medicatieafspraak | MBH_413_3_MA_1 | ||||||||
MBH identificatie | MBH_413_3 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 20 dagen, om 10:26 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||||||||
Toedieningsweg | cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 3 maal per dag | ||||||||
Relatie naar medicatieafspraak | MBH_413_4_MA_1 | ||||||||
MBH identificatie | MBH_413_4 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 20 dagen, om 10:46 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_413_5_MA_1 | ||||||||
MBH identificatie | MBH_413_5 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||||||||
Toedieningsweg | niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||||||||
Relatie naar medicatieafspraak | MBH_413_6_MA_1 | ||||||||
MBH identificatie | MBH_413_6 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_7_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||||||||
Relatie naar medicatieafspraak | MBH_413_7_MA_1 | ||||||||
MBH identificatie | MBH_413_7 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_8_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 10 weken | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | op maandag, woensdag en vrijdag | ||||||||
Relatie naar medicatieafspraak | MBH_413_8_MA_1 | ||||||||
MBH identificatie | MBH_413_8 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_9_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||||||||
Relatie naar medicatieafspraak | MBH_413_9_MA_1 | ||||||||
MBH identificatie | MBH_413_9 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_10_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||||||||
Herhaalperiode cyclisch schema | 28 dagen | ||||||||
Relatie naar medicatieafspraak | MBH_413_10_MA_1 | ||||||||
MBH identificatie | MBH_413_10 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_11_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 41 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | FUCIDIN CREME 20MG/G (code = '420956' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||||||||
Toedieningsweg | cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||||||||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||||||||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||||||||
Relatie naar medicatieafspraak | MBH_413_11_MA_1 | ||||||||
MBH identificatie | MBH_413_11 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_12_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | bij hoest 3 à 4 maal per uur 1 stuk | ||||||||
Relatie naar medicatieafspraak | MBH_413_12_MA_1 | ||||||||
MBH identificatie | MBH_413_12 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_13_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 28 dagen, om 09:12 | ||||||||
Gebruiksperiode | Vanaf T- 28 dagen, gedurende 8 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 0.5 ml per uur | ||||||||
Relatie naar medicatieafspraak | MBH_413_13_MA_1 | ||||||||
MBH identificatie | MBH_413_13 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_13_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T- 20 dagen, om 11:25 | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 8 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 0.2 à 0.5 ml per uur | ||||||||
Relatie naar medicatieafspraak | MBH_413_13_MA_2 | ||||||||
MBH identificatie | MBH_413_13 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_14_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 11:25 | ||||||||
Gebruiksperiode | Vanaf 2018-08-16T00:00:00, tot nader order | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf 2018-08-16T00:00:00, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||||||||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||||||||
Relatie naar medicatieafspraak | MBH_413_14_MA_1 | ||||||||
MBH identificatie | MBH_413_14 |
Toedieningsafspraak | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_15_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||||||
Afspraakdatum | T, om 09:35 | ||||||||
Gebruiksperiode | Vanaf T, gedurende 4 dagen | ||||||||
Verstrekker | Apotheek De Gulle Gaper | ||||||||
Geneesmiddel - Product specificatie | |||||||||
Product naam | Haparine 100 ie= 10 ml | ||||||||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||||||||
Farmaceutische vorm | vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||||||||
Ingredient | |||||||||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 100 internationale eenheid per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 1 stuk per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 0.09 gram per 10 ml | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 10 ml | ||||||||
Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||||||||
MBH identificatie | MBH_413_15 |
Verstrekkingen XXX_Strengersz
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_9_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T, om 10:35 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 90 stuks | ||||||||
Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||||||||
Distributievorm | Geïndividualiseerd distributiesysteem (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||||||||
MBH identificatie | MBH_413_9 |
Verstrekking | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_15_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||||||
Datum | T, om 10:35 | ||||||||
Verstrekker | Apotheek de Gulle Gaper | ||||||||
Verstrekte hoeveelheid | 100 ml | ||||||||
Geneesmiddel - Product specificatie | |||||||||
Product naam | Haparine 100 ie= 10 ml | ||||||||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||||||||
Farmaceutische vorm | vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||||||||
Ingredient | |||||||||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 100 internationale eenheid per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 1 stuk per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 0.09 gram per 10 ml | ||||||||
Relatie naar verstrekkingsverzoek | MBH_513_15_VV_1 | ||||||||
MBH identificatie | MBH_413_15 |
Medicatiegebruik XXX_Strengersz
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 16:25 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||||||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_413_1_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_1 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 14:25 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | exact iedere 3 uur 16 internationale eenheid | ||||||||
Gerelateerde afspraak : MA | MBH_413_2_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_2 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 10:45 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||||||||
Gerelateerde afspraak : MA | MBH_413_3_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_3 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T- 15 dagen, om 13:44 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59, 3 maal per dag aanbrengen, cutaan | ||||||||
Toedieningsweg | cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 3 maal per dag | ||||||||
Gerelateerde afspraak : MA | MBH_413_4_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_4 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 12:38 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_413_5_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_5 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 21:37 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||||||||
Toedieningsweg | niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||||||||
Gerelateerde afspraak : MA | MBH_413_6_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_6 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_7_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 14:05 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T, om 14:00, tot en met T, om 14:05 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, om 14:00, tot en met T, om 14:05, om 14:00 16IE | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | elke dag om 16 internationale eenheid | ||||||||
Gerelateerde afspraak : MA | MBH_413_7_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_7 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_7_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 20:10 | ||||||||
Gebruik indicator | true | ||||||||
Gebruiksperiode | Vanaf T, om 20:00, tot en met T, om 20:05 | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, om 20:00, tot en met T, om 20:05, om 20:00 16IE | ||||||||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | elke dag om 16 internationale eenheid | ||||||||
Gerelateerde afspraak : MA | MBH_413_7_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_7 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_8_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 23:59 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 10 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||||||||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||||||||
Doseerinstructie | op maandag, woensdag en vrijdag | ||||||||
Gerelateerde afspraak : MA | MBH_413_8_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_8 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_9_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 22:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||||||||
Gerelateerde afspraak : MA | MBH_413_9_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_9 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_10_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 09:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, tot nader order | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||||||||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||||||||
Herhaalperiode cyclisch schema | 28 dagen | ||||||||
Gerelateerde afspraak : MA | MBH_413_10_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_10 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_11_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 15:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 41 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||||||||
Aanvullende instructie | dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||||||||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||||||||
Doseerinstructie | dan gedurende 3 weken 1 maal per dag 2 gram | ||||||||
Doseerinstructie | dan gedurende 6 dagen 1 maal per dag 1 gram | ||||||||
Gerelateerde afspraak : MA | MBH_413_11_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_11 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_12_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 22:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||||||||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | bij hoest 3 à 4 maal per uur 1 stuk | ||||||||
Gerelateerde afspraak : MA | MBH_413_12_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_12 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_14_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 22:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||||||||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||||||||
Gerelateerde afspraak : MA | MBH_413_14_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_14 |
Medicatie gebruik | |||||||||
Gegevenselement | Waarde | ||||||||
Identificatie | MBH_413_15_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||||||
Registratiedatum | T, om 10:35 | ||||||||
Gebruik indicator | true | ||||||||
Volgens afspraak indicator | true | ||||||||
Gebruiksperiode | Vanaf T, gedurende 4 dagen | ||||||||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||||||||
Geneesmiddel - Product specificatie | |||||||||
Product naam | Haparine 100 ie= 10 ml | ||||||||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||||||||
Farmaceutische vorm | vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||||||||
Ingredient | |||||||||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 100 internationale eenheid per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 1 stuk per 10 ml | ||||||||
Ingredient | |||||||||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||||||||
Sterkte | 0.09 gram per 10 ml | ||||||||
Gebruiksinstructie | |||||||||
Omschrijving | Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||||||||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||||||||
Doseerinstructie | 2 maal per dag 10 ml | ||||||||
Gerelateerde afspraak : MA | MBH_413_15_MA_1 | ||||||||
Auteur | Patiënt | ||||||||
MBH identificatie | MBH_413_15 |